Biography and Research Information
OverviewAI-generated summary
Barrett J. Burger's research focuses on the intersection of critical care, pharmacology, and specific disease states. Burger has published work investigating the association between the drug tocilizumab and an increased risk of fungal infections in critically ill COVID-19 patients with acute renal failure. This line of inquiry has been the subject of multiple publications since 2021. Additionally, Burger's research has explored patient preparedness for medical procedures, including the systematic identification of pre-procedural anxiety and literacy prior to flexible bronchoscopy. Burger has also contributed to the literature on respiratory conditions, with publications addressing spontaneous pneumothorax and pleuropulmonary blastoma.
Metrics
- h-index: 3
- Publications: 8
- Citations: 52
Selected Publications
-
Spontaneous pneumothorax or no pneumothorax at all? (2023)
-
Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study (2023)
-
Pleuropulmonary Blastoma Presenting as Tension Pneumothorax (2022)
-
Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study. (2021)
-
Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 (2021)
Collaboration Network
Top Collaborators
Nikhil Meena
4 shared publications
In database
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
- SYSTEMATIC IDENTIFICATION OF PRE-PROCEDURAL ANXIETY AND LITERACY PRIOR TO FLEXIBLE BRONCHOSCOPY
Sarenthia M. Epps
University of Arkansas for Medical Sciences
3 shared publications
In database
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
Víctor M. Cárdenas
University of Arkansas for Medical Sciences (US)
3 shared publications
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
Rajani Jagana
University of Arkansas for Medical Sciences
3 shared publications
In database
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
William T. Atchley
University of Arkansas for Medical Sciences
3 shared publications
In database
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
M. Pertzborn
Arkansas Children's Hospital
2 shared publications
In database
- Pleuropulmonary Blastoma Presenting as Tension Pneumothorax
- Spontaneous pneumothorax or no pneumothorax at all?
Kevin Bielamowicz
Arkansas Children's Hospital
2 shared publications
In database
- Pleuropulmonary Blastoma Presenting as Tension Pneumothorax
- Spontaneous pneumothorax or no pneumothorax at all?
Z. Ghazala
Arkansas Children's Hospital
2 shared publications
In database
- Pleuropulmonary Blastoma Presenting as Tension Pneumothorax
- Spontaneous pneumothorax or no pneumothorax at all?
JAKE SMITH
1 shared publication
- SYSTEMATIC IDENTIFICATION OF PRE-PROCEDURAL ANXIETY AND LITERACY PRIOR TO FLEXIBLE BRONCHOSCOPY
MOHAMMAD KHRAIS
1 shared publication
- SYSTEMATIC IDENTIFICATION OF PRE-PROCEDURAL ANXIETY AND LITERACY PRIOR TO FLEXIBLE BRONCHOSCOPY
Similar Researchers
Based on overlapping research topics
Jorge Brito
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Pharmacological Effects and Toxicity Studies
Microbial infections and disease research
Shi J. Liu
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Pharmacological Effects and Toxicity Studies
Microbial infections and disease research
Sarenthia M. Epps
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Pharmacological Effects and Toxicity Studies
Microbial infections and disease research
Adriana Sarmiento Clemente
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Pharmacological Effects and Toxicity Studies
Microbial infections and disease research
Kwame G. Yeboah
Harding University Main Campus
Pharmacological Effects and Toxicity Studies
Microbial infections and disease research
Immune Response and Inflammation
Ines Berger
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Immune Response and Inflammation